|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
9 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross loss | |||||
| Operating Expenses: | |||||
| General and administrative (including stock-based compensation of $1,626,102 and $4,287,236, respectively) | |||||
| Sales and marketing | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other (income) expense: | |||||
| Interest expense | |||||
| Other income | |||||
| Unrealized gain on other investments | |||||
| Total other (income) expense | |||||
| Income (Loss) before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net Income (Loss) | |||||
| Less cumulative preferred stock dividends | |||||
| Deemed dividend from warrant exchange offer | |||||
| Cumulative preferred stock dividends | |||||
| Net Income (Loss) to common stockholders | |||||
| Basic net income (loss) per share | |||||
| Diluted net income (loss) per share | |||||
| Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic | |||||
| Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted | |||||
Loading...